| Finding | Percentage | Cases |
|---|---|---|
| Gender | ||
| Male | 31.8% | 7/22 |
| Female | 68.2% | 15/22 |
| Indifferent | 0% | 0/22 |
| Unknown | 0% | 0/22 |
| General | ||
| Birth Length | 0% | 0/5 |
| 10.5% | 2/19 | |
| 20% | 1/5 | |
| 15% | 3/20 | |
| 35.3% | 6/17 | |
| 40% | 8/20 | |
| 100% | 18/18 | |
| 100% | 22/22 | |
| 100% | 22/22 | |
| 93.8% | 15/16 | |
| Neurology | ||
| 100% | 22/22 | |
| 77.3% | 17/22 | |
| 50% | 11/22 | |
| Facial abnormalities | ||
| 9.1% | 2/22 | |
| 100% | 22/22 | |
| 9.1% | 2/22 | |
| 100% | 22/22 | |
| Visual and hearing impairments | ||
| 31.8% | 7/22 | |
| 4.5% | 1/22 | |
| Heart | ||
| 31.8% | 7/22 | |
| Pulmonary | ||
| Abnormality of the lungs | 0% | 0/3 |
| Gastrointestinal | ||
| 40.9% | 9/22 | |
| Urogenital | ||
| 18.2% | 4/22 | |
| Skeleton | ||
| 22.7% | 5/22 | |
| Skin / Hair / Nails | ||
| 4.5% | 1/22 | |
| Endocrine / Immunological / Metabolic | ||
| 9.1% | 2/22 | |
| Metabolic | 0% | 0/22 |
| 9.1% | 2/22 | |
| Neoplasia | ||
| Neoplasia | 0% | 0/22 |
| Inheritance | ||
| 100% | 5/5 | |
EHMT1